{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "D",
          "position": "309"
        },
        "variant_string_id": "PINK1 G309D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 are associated with recessive parkinsonism. The encoded protein is a mitochondrial Ser/Thr kinase, and loss of kinase activity is implicated in disease pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links PINK1 mutations to recessive parkinsonism and describes the protein's role as a mitochondrial kinase, establishing a clear disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "In vitro kinase activity assays and mammalian cell localization experiments were used to assess the functional impact of mutations.",
          "judgment": "Yes",
          "reasoning": "Kinase activity assays directly model the molecular mechanism of PINK1 dysfunction in Parkinson's disease, making the assays relevant to the disease mechanism.",
          "next_step": "Step 3"
        },
        {
          "step_name": "Step 3a: Check controls and replicates",
          "extracted_paper_info": "The study created 'kinase-dead' mutants as controls, which were stable but lacked activity. Experiments were performed in vitro.",
          "judgment": "Yes",
          "reasoning": "Controls (wild-type vs. kinase-dead mutants) were explicitly mentioned, and in vitro experiments typically involve replicates."
        },
        {
          "step_name": "Step 3c: Variant controls",
          "extracted_paper_info": "Kinase-dead mutants were used as positive controls for loss-of-function effects.",
          "judgment": "Yes",
          "reasoning": "The study utilized known pathogenic controls (kinase-dead mutants) to validate the assay's ability to detect functional deficits."
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study reported qualitative effects (e.g., 'modest effects' for G309D, 'drastically reduces' for L347P) but no quantitative statistical analyses or OddsPath values.",
          "judgment": "No",
          "reasoning": "No statistical analyses or OddsPath values were reported, so the analysis proceeds to Step 4b."
        },
        {
          "step_name": "Step 4b: Number of controls",
          "extracted_paper_info": "The study evaluated two variants (G309D and L347P) and used kinase-dead mutants as controls. Total controls: ~4 (2 variants + 2 mutants).",
          "judgment": "No",
          "reasoning": "Total controls (4) are fewer than 10, resulting in 'Max PS3_supporting' evidence strength."
        }
      ],
      "evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "347"
        },
        "variant_string_id": "PINK1 L347P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 are associated with recessive parkinsonism. The encoded protein is a mitochondrial Ser/Thr kinase, and loss of kinase activity is implicated in disease pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links PINK1 mutations to recessive parkinsonism and describes the protein's role as a mitochondrial kinase, establishing a clear disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "In vitro kinase activity assays and mammalian cell localization experiments were used to assess the functional impact of mutations.",
          "judgment": "Yes",
          "reasoning": "Kinase activity assays directly model the molecular mechanism of PINK1 dysfunction in Parkinson's disease, making the assays relevant to the disease mechanism.",
          "next_step": "Step 3"
        },
        {
          "step_name": "Step 3a: Check controls and replicates",
          "extracted_paper_info": "The study created 'kinase-dead' mutants as controls, which were stable but lacked activity. Experiments were performed in vitro.",
          "judgment": "Yes",
          "reasoning": "Controls (wild-type vs. kinase-dead mutants) were explicitly mentioned, and in vitro experiments typically involve replicates."
        },
        {
          "step_name": "Step 3c: Variant controls",
          "extracted_paper_info": "Kinase-dead mutants were used as positive controls for loss-of-function effects.",
          "judgment": "Yes",
          "reasoning": "The study utilized known pathogenic controls (kinase-dead mutants) to validate the assay's ability to detect functional deficits."
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study reported qualitative effects (e.g., 'modest effects' for G309D, 'drastically reduces' for L347P) but no quantitative statistical analyses or OddsPath values.",
          "judgment": "No",
          "reasoning": "No statistical analyses or OddsPath values were reported, so the analysis proceeds to Step 4b."
        },
        {
          "step_name": "Step 4b: Number of controls",
          "extracted_paper_info": "The study evaluated two variants (G309D and L347P) and used kinase-dead mutants as controls. Total controls: ~4 (2 variants + 2 mutants).",
          "judgment": "No",
          "reasoning": "Total controls (4) are fewer than 10, resulting in 'Max PS3_supporting' evidence strength."
        }
      ],
      "evidence_strength": "PS3_supporting"
    }
  ]
}